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ABSTRACT 
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Abstract 
Airborne exposure to particulate matter with diameter <10µm (PM10) has been linked to an 
increased risk of thromboembolic events, but the mechanisms are not completely 
understood. The aim of this study is to evaluate the effect of PM10 phagocytosis on the 
release of procoagulant molecules in human differentiating macrophages, and that of PM10 
inhalation in an experimental model in rats. Human monocytes were separated from the 
peripheral blood by the lymphoprep method, differentiated in vitro, and treated with 
standard PM10 or vehicle. Sprague-Dawley rats were instilled intra-tracheally with PM10 or 
vehicle alone. The outcome was expression of proinflammatory genes and of tissue factor 
(TF). In human differentiating macrophages, PM10 exposure upregulated inflammatory 
genes, but most consistently induced TF mRNA and protein levels, but not TF protein 
inhibitor, resulting in increased TF membrane expression and a procoagulant phenotype. 
Differentiation towards the anti-inflammatory M2 phenotype inhibited PM10-mediated TF 
expression. TF induction required phagocytosis of PM10, whereas phagocytosis of inert 
particles was less effective. PM10 phagocytosis was associated with a gene expression 
profile consistent with intracellular retention of iron, inducing oxidative stress. Both PM10 
and iron activated the stress kinases ERK1/2 pathway, involved in the induction of TF 
expression. In rats, alveolar exposure to PM10 was associated with pulmonary recruitment 
of inflammatory cells and resulted in local, but not systemic, induction of TF expression, 
which was sufficient to increase circulating TF levels. In conclusion, TF induction by 
differentiating lung macrophages, activated following phagocytosis, contributes to the 
increased risk of thromboembolic complications associated with PM10 exposure. 
 
Short abstract 
Here we show that in human differentiating macrophages, particulate matter with diameter 
<10µm (PM10) exposure induces Tissue Factor (TF) and a procoagulant phenotype. This 
process is dependent on phagocytosis and the activation of stress pathways, and is 
abolished in differentiated anti-inflammatory macrophages. In rats, alveolar exposure to 
PM10 causes the recruitment of inflammatory cells and results in local induction of TF, 
increasing circulating TF levels. TF induction by differentiating lung macrophages, 
contributes to the increased risk of thromboembolic complications associated with PM10 
exposure. 
 
Keywords: coagulation; inflammation; lung; macrophage; monocyte; particulate matter; 
phagocytosis; tissue factor. 
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Introduction 
Since the 1952 Great Smog of London is known that air pollution has wide-ranging and 
deleterious effects on human health (Wilkins et al., 1956). 
In fact, as a consequence of stagnant weather conditions there was a severe increase in 
the concentrations of air pollutans and over the next several days, mortality in the 
population was more than three-fold times than expected, leading to an estimated excess 
of 4000 deaths (Brunekreef B et al., 2002).  
The environmental changes promoted by humans as a result of changes in lifestyles, 
customs, and technologies have repercussions for both health and quality of life. Exposure 
to atmospheric pollutants, generated in both open and closed environments, is a major 
cause of morbidity and mortality that may be both controlled and minimized. Today, air 
pollution is a major public health concern in the United States and worldwide, accounting 
for approximately 800,000 deaths annually (The World Health Report 2014). 
Epidemiological studies have demonstrated that peaks in ambient concentrations  of air 
particulate matter (PM) pollution, of which traffic is a major source, are rapidly followed, 
within hours or days after exposure, by increased hospitalization and death, particularly 
from cardiovascular disease (CVD) and pulmonary disorders (Brook RD et al., 2010; 
Zheng XY et al., 2015). 
Recent studies also suggest a  possible link between ambient air PM and development of 
obesity, type-2 diabetes and neurodegenerative diseases (Sun Q et al., 2009; Xu X et al., 
2010; Calderon-Garciduenas L et al., 2008). 
For these reasons the study of the impact of particulate matter on human health plays a 
pivotal role in the present days. 
 
Particle toxicology 
Outdoor air pollution is a heterogeneous, complex group of compounds from various 
sources, including transition metals, sulphate and nitrate salts, and carbon (Wilson and 
Suh 1997). A number of factors affect the toxicity of particles, including size, shape, 
structure, surface reactivity, solubility, persistence and presence of soluble components. 
Particles are often classified into three major groups: coarse particles, with a diameter 
between 10 and 2.5 µm; fine particles with diameter between 2.5 and 0.1 µm and 
ultrafine particles with diameter lower than 0.1 µm. Coarse particles generally originate 
from wear-processes, such as road and tire abrasion, construction work or from natural 
windblown dusts. The fine and ultrafine fractions tend to be dominated by particles from a 
combustion process (Fig. 1). 
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PM is associated with the most severe air pollution-induced health effects. Like other 
components of air pollution, PM may contain toxic substances and transport them into the 
respiratory tract. The effect of PM on the body depend on PM size, which is related to its 
aerodynamic diameter. Generally small particles are more toxic than larger ones due to a 
larger surface-to-mass-ratio. Most PM10 particles have a diameter range from 2.5 to 10µm, 
and are deposited in the nasal cavities and upper airways. However, PM2.5 and PM0.1 
particles with diameter <2.5 µm and <0.1 µm, respectively, may penetrate the lung alveoli 
and enter into the bloodstream (Franck U et al., 2011). Shape and physicochemical 
structure also affect the toxicity of particles. Long and thin fibers (<15 µm) are more 
hazardous than short fibers or spherical particles, because they cannot be completely 
removed by alveolar macrophages (Donaldson K et al., 2002). Surface reactivity, such as 
surface charge or presence of reactivity group or redox-active transition metals may also 
affect the toxicity of particles. The presence of soluble toxic components on the particle 
surface, such as metal ions, organic compounds including polycylic aromatic hydrocarbons 
(PAHs) and biological materials such as bacterial endotoxins or allergens are also 
important mediators of adverse effects from particle exposure. Soluble particles tend to be 
less harmful than insoluble fraction, because the retention and the biopersistence of 
insoluble particles in lung or in other organs may promote more damage. 
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FIG 1. Sources, dimensions and composition of Particulate Matter (PM). 
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Air Pollution and Cardiovascular Diseases (CVD) 
 
It’s known that airborne exposure to fine particulate matter (PM) contributes to the 
susceptibility to cardiovascular events. Moreover cardiovascular disease (CVD) is the 
leading cause of morbidity and mortality in western countries, which are also characterized 
by high level of air pollution. Indeed, high concentrations of PM have been associated with 
cardiovascular morbidity and mortality in both short- and long-term epidemiological 
studies.  
Since the 2004, the American Hearth Association (AHA) underlined that the exposure to 
high concentration of PM is associated with an increased risk for cardiovascular events 
such as myocardial infarction (MI), stroke, arrhythmias, heart failure and atherosclerosis. 
(Brook RD et al., 2004). In 2010, an updated scientific statement of AHA defined PM2.5 
exposure as a “modifiable factor that contributes to cardiovascular mortality and morbidity” 
(Brook RD et al., 2010). It has been shown that short-term exposure to PM2.5 triggers both 
fatal and non fatal event, while long term exposure to the same particles is associated with 
an even greater reduction of life expectancy (Kloog I et al., 2012).  
There are differences between short and long exposure. A very short exposure (few days) 
to increased PM concentration has been consistently associated with higher 
cardiovascular mortality for both PM10 (+0.6-1.8% for an increase of 20µg/m3) and PM2.5 
(+0.6-1.3% for an increase of 10 µg/m3) (Brook RD et al. 2010). The finest PM2.5 appeared 
to have a higher impact on cardiovascular mortality than the coarse PM, which 
nonetheless remained independently associated with mortality risk (+30% for an increase 
of 10 µg/m3) (Zanobetti A et al., 2009). 
However a long exposure to PM had more harmful effects. In the seminal Harvard Six 
Cities Study, living in the PM most polluted cities was associated with a more than 30% 
increased risk of cardiovascular mortality (Dockery DW et al., 1993). In other studies, 
PM2.5 exposure was associated with a more than 10% increased risk of cardiovascular 
mortality for an increase of 10 µg/m3 (Brook RD et al., 2010).  
Beyond these effects on mortality, PM concentration has been related with cardiovascular 
morbidity in several studies. For example the analysis of Medicare data in 204 U.S. cities 
showed that a rise of in PM2.5 concentration was associated with an increase of hospital 
admissions for ischemic heart disease (+0.44%), cerebrovascular disease (+0.81%), 
peripheral arterial disease (+0.86%), arrhythmias (+0.57%) and heart failure (+1.28%). In 
this study the effects of PM exposure were very early, with an increase of hospitalization 
  11 
during the first day of high PM levels, even if the effect on ischemic heart disease was 
more evident after two days of exposure. (Dominici F et al., 2006). 
The main cause of mortality due to PM air pollution is ischemic heart disease, which is 
associated with both short- and long-term exposures (Puett RC et al., 2008). Peters and 
colleagues suggested that even few hours exposure to urban traffic may increase the risk 
of myocardial infarction (Peters et al., 2004). 
Beyond ischemic heart disease, PM air pollution has been linked with other clinical 
manifestations of CVD. Long PM2.5 exposure was associated with mortality attributable to 
heart failure, arrhythmias and cardiac arrest, although with a relative risk lower than that of 
ischemic heart disease (RR 1.13 versus 1.18 per 10 µg/m3 increase) (Pope CA et al., 
2006). More consistent results have linked PM air pollution with cerebrovascular disease, 
particularly with ischemic stroke. In the Women’s Health Initiative study an increase of 10 
µg/m3 in PM2.5 concentration raised the risk of both fatal (RR=1.83) and non fatal stroke 
(RR=1.35) (Miller KA et al., 2007). Moreover recents studies suggest that atherotrombotic 
diseases such as myocardial infarction and ischemic stroke have a prominent 
mechanicistic role in the increase of mortality rate associated with PM exposure 
(Bhatnagar A et al., 2006). Several potential mechanism have been postulated to cause 
the increase in atherotrombotic events, such as activation of inflammatory pathways, 
production of reactive oxygen species and alterations in vascular tone (Pope CA et al., 
2004). There is another study showing that fine particulate exposure accelerates the 
development of atherosclerosis in animal model (Sun Q et al., 2005). 
Recent studies have also connected PM exposure with cognitive impairment, adding a 
new viewpoint on the harmful effects of air pollution (Weuve J et al., 2012).  
Finally some studies have suggested an association of PM with venous thromboembolism. 
This association has been found with PM10 and coarse PM10-2.5 (Baccarelli A et al., 2012), 
rather than only with the finest PM2.5 (Dales RE et al., 2010). Today there are enough 
evidences to consider PM as a possible acquired risk factor for venous thromboembolism, 
and both hypercoagulability and inflammation play a pivotal role in this association. In fact, 
these pathological mechanisms are closely related. It’s known that PM intratracheal 
instillation enhance thrombus formation through platelet activation in hamster model 
(Nemmar A et al., 2002). Other experiments show how inhalation of PM, with its toxic 
substances, followed by translocation into the bloodstream, leads to the activation of 
platelets and coagulation factors. Hypercoagulability and heightened platelet activation 
also occur through pulmonary and systemic inflammation and generate a cytokine storm, a 
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mechanism that facilitates atherogenesis (Vermylen j et al., 2007). Baccarelli et al., 
demonstrated that a global coagulation test like prothrombin time (PT) becomes shorter 
during exposure to high ambient air concentrations of PM10 (Baccarelli A et al., 2007). 
This result was confirmed by Bonzini et al., who used for the first time a global functional 
assay of coagulability (the thrombin generation test) and demonstrated heightened 
thrombin formation in steel workers, who were exposed to high levels of particulate matter 
(Bonzini M et al., 2010). 
Very recent epidemiological studies evaluate the effect of air pollution exposure on 
thromboembolism. Baccarelli et al., examined the relationship between exposure to PM10 
and the occurrence of deep vein thrombosis (DVT) in 870 patients and 1270 healthy 
subjects from the lombardy region, and found that for each increase of 10 ng mm-3 in PM10 
levels there was a 70% increase in the risk of DVT, independent of other clinical and 
environmental variables. In the same study they also confirmed that exposure to PM was 
associated with a shortened PT, extending their previous observations based on a shorter 
time window of exposure to pollution (Baccarelli A et al., 2008).  
The association between air pollution and deep vein thrombosis was independently 
replicated by Dales et al., (Dales RE et al., 2010) who report that the short term increase 
of hospital admissions for venous thrombosis and pulmonary embolism in Santiago is 
proportional to the concentration of particulate and gaseous air pollutants.  
Nevertheless, caution is required since other studies did not find any significant 
associations between venous thromboembolism and traffic exposure or PM 
concentrations, so more investigations in this field are required (Kan H et al., 2011; Shih 
RA et al., 2011). 
 
Are specific subjects more susceptible? 
 
Some groups of subjects are more susceptible to the harmful effects of PM exposure. 
These groups include elderly subjects, diabetic patients and individuals with coronary 
artery disease (Brook RD et al., 2010; Fossati S et al, 2014). Also obesity and female 
gender have been proposed as possible susceptibility factors, while the interaction 
between smoking and PM exposure in determining cardiovascular effect is controversial 
(Kan H et al., 2008). However in a study designed by Baccarelli et al., (Baccarelli A et al., 
2008) PM10 exposure did not increase the risk of deep vein thrombosis in women as much 
in men. However, the use of oral contraceptives and hormone therapy induce changes in 
coagulation factors, such as increased levels of procoagulant factors VII, IX, X, XII, XIII, 
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von Willebrand factor and fibrinogen and reduced levels of the anticoagulant proteins 
antithrombin and protein S. These mechanisms are similar to those activated by air 
pollution, so the authors speculate that women undergo less or no further induction after 
air particle exposure because the prothrombotic mechanisms are already activated. Also 
genetic host factors are implicate in pathophysiological mechanism of PM exposure. It’s 
known that many different polymorphisms in various candidate genes can modulate PM-
related cardiovascular outcome (Zanobetti A et al., 2011). In particular, the genes 
implicated are those involved in oxidative and inflammatory pathways such as glutathione 
S-transferases (GSTM1, GSTp1, GSTT1), interleukin 6 (IL-6), fibrinogen (FG-A/B/G), 
vascular endothelial growth factors (VEGF-A/B), apolipoprotein E (APOE), 
hemochromatosis protein (HFE). These genes have significant interactions with PM in 
determining heterogeneous cardiovascular phenotypes. One of the most interesting 
genetic factor that modifies pathophysiological effects of particulate matter is the 
hemochromatosis (HFE) gene. Park et al., (Park SK et al., 2006) found that the effect of 
particles on cardiac autonomic function is attenuated in subjects with at least 1 copy of an 
HFE variant compared with wild type subjects. Variants in the HFE gene are associated 
with increased iron uptake in the cells, in particular macrophages. Macrophages of 
subjects with HFE variant may reduce immediate absorption of toxic metals in particulate 
matter, because subjects with this variant have higher iron stores and downregulated iron 
absorption. 
 
Pathophysiological mechanism linking particulate matter (PM) and cardiovascular 
disease (CVD) 
Three main mechanisms have been recognised to promote extrapulmonary effects of PM 
on cardiovascular system: first of all the release of pro-inflammatory mediators from lung 
cells after PM stimulation; second, the influence on autonomic nervous system induced by 
PM interactions with lung receptors; and last the direct translocation of ultrafine PM (<0.1 
µm) into the bloodstream. PM triggers pulmonary oxidative stress and inflammation by 
heterogeneous and complex mechanisms, with several responses according to different 
properties of PM particles. Indeed the ultrafine particles may directly enter cells via non-
phagocytic pathways and then impair intracellular organelles like mitochondria (Mühlfeld C 
et al. 2008); Ultrafine particulate has also been demonstrated to promote vascular 
calcification by activating NFKB signaling (Li R et al., 2013).  
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On the other hand, larger PM enters cells by phagocytosis through interactions with innate 
immunity receptors like MARCO, MAcrophage Receptor with COllagenous structure 
(Møller P et al., 2010). Coarse PM has been suggested to directly trigger inflammation by 
binding toll-like receptor 2 and 4 (TLR2-4) (Becker S et al., 2005). PM can generate 
Reactive Oxygen Species (ROS) both directly and indirectly. In fact PM incubation has 
been shown to activate ROS-generating pathways in both pulmonary and vascular tissues 
(Li Z et al., 2013; Michael S et al., 2013). On the other hand several inflammatory 
mediators that are released from the lung cells after contact with PM may spread to 
general circulation, where they can plausibly modulate systemic effects. Numerous 
inflammatory cytokines like IL-6, IL-1β, TNF-α, IFN-γ have been shown to be increased in 
circulating blood after PM exposure in both animal and human studies (Hartz AM et al., 
2008; Törnqvist H et al., 2007).  
Another potentially detrimental effect of PM exposure is an abnormal activation of the 
haemostatic system. It’s known that in animal models, the instillation of PM intratracheally 
induced lung inflammation, platelet activation and increased peripheral thrombosis after 
photochemical injury (Nemmar A et al., 2003).  
Another possible prothrombotic mechanism is represented by circulating microvesicles. 
Indeed prolonged exposure to air pollutans increases both the number of procoagulant 
vescicles and their procoagulant properties (Emmerechts J et al., 2012).  
Moreover PM particles are thought to stimulate autonomic nervous system, impairing 
autonomic balance and favouring sympathetic over parasympathetic tone. This may 
contribute to the increased cardiovascular risk through the induction of pro-hypertensive 
vasoconstriction and the predisposition to arrhytmias (Rhoden CR et al., 2005).  
 
Air pollution, blood pressure and coagulation 
 
Numerous studies assessing the relationship between air pollution and cardiovascular 
disease have also investigated changes in blood pressure. It’s well known that both air 
pollution and increased blood pressure contribute to an elevated cardiovascular risk. 
It has been indicated that for every 10.5 µg/m3 increase in PM2.5 levels, there was a 2.8 
mmHg increase in systolic blood pressure and 2.7 mmHg increase in diastolic blood 
pressure in patients over 5 days in Boston. (Brook RD et al., 2007). According to this study 
there is a close correlation between increased blood pressure and PM. 
It’s known from 1995 (Seaton A et al., 1995) that inhaled pollutans induce alveolar 
inflammation with release of mediators capable of increasing blood coagulability. The 
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contribution of inflammation to blood coagulation is the de novo synthesis of tissue factor 
(TF) on leukocytes and endothelial cells stimulated by inflammatory cytokines, acute 
phase C-reactive protein and reactive oxygen species (Lindmark E et al., 2000; Eilertsen 
KE et al., 2004). Moreover coagulation factors such as FVII and fibrinogen, which are part 
of the acute phase responses mediated by cytokines released during inflammatory 
reactions, increase after short-term exposure to particles (Schwartz J et al., 2001; Ruckerl 
R et al., 2014). As already mentioned before, Baccarelli et al., (Baccarelli et al., 2007) 
founded that a shorter prothrombin time (PT) was associated with higher concentrations of 
ambient PM10, CO and NO2. This suggests that air pollution determines hypercoagulability 
and contributes to the increase in cardiovascular effects observed after exposure to air 
pollution.  
Esmon et al., sustained that, in case of infection, coagulation and inflammation are closely 
related. Inflammation leads to tissue factor induction, leucocytes adhesion, 
thrombomodulin down regulation and complement activation. Coagulation triggers platelet 
activation and leads to P selectin and CD40 ligand expression platelet surface. Thus 
coagulation increases inflammation that in turn increases coagulation. (Esmon CT et al., 
2011).  
 
 
FIG.1. The impact of coagulation on inflammation and the impact of inflammation on coagulation.  
 
Activation of coagulation and deposition of fibrin as a consequence of inflammation can be 
considered useful in containing inflammatory activity to the site of the injury, rendering this 
relationship physiologically efficient. The main mediators of inflammation-induced 
coagulation are pro-inflammatory cytokines like Interleukin-6 (IL-6) in the initiation of 
coagulation activation and tumor necrosis factor α (TNF- α) and Interleukin-1 (IL-1) in the 
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regulation of physiological anticoagulation. Tissue factor (TF) possesses a central role in 
the inititiation of inflammation-induced coagulation, in fact blocking tissue factor activity the 
inflammation-induced thrombin generation was completely inhibited in models of 
experimental endotoxemia and bacteremia (Levi M et al., 1994). 
It’s known that inflammatory cytokines promote the activation of coagulation through the 
induction of tissue factor and the downregulation of thrombomodulin. In fact during acute 
inflammatory conditions, the pro-coagulant response is characterized by increased cellular 
expression of Tissue factor (TF), the physiological trigger of coagulation. In addition a loss 
of endogenous anticoagulant activity is proposed to occur during inflammation, mainly 
based on the loss of thrombomodulin (TM). Frederix et al., demonstrated that pulmonary 
instillation of PM induced TF activity as well as concurrent loss of TM associated activity in 
a concentration dependent manner. (Frederix K et al, 2008).  
In another study the link between air pollution exposure and an hypercoagulability state 
was further emphasized by the simultaneous increase in C-reactive protein (Bonzini M et 
al., 2010). 
 
 
Tissue Factor (TF) 
A plausible mechanism that contributes to PM10-mediated hypercoagulability is the 
induction of Tissue Factor (TF) (Gilmour, et al. 2005, Karoly, et al. 2007, Snow, et al. 2014, 
Steffel, et al. 2006, van den Eijnden, et al. 1997). Tissue factor (TF), also known as 
thromboplastin or CD142, is the physiological trigger of coagulation cascade (Fig. 2) (Bach 
RR et al., 1988).  
The coagulation cascade is initiated as soon as TF comes into contact with circulating 
activated factor VII (VIIa) resulting in TF-FVIIa complex. The TF-FVIIa complex activates 
factor IX, which in turn activates factor X. In complex with Factor Va and calcium, Factor 
Xa catalyzes the conversion of prothrombin to thrombin, thereby leading to fibrin formation, 
platelet activation and generation of a thrombus. It’s a transmembrane cell surface 
glycoprotein, essential not only for the coagulation process. In fact mice knockout for TF 
die between embryonic day 8.5 and 10.5 as a consequence of defective vascular integrity 
and neoangiogenesis (Carmeliet P et al., 1996).  
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Fig. 2. (A) Upstream coagulation factors are activated by substances exposed by vessel injury; chief among 
these factors is Tissue Factor (TF). Activated upstream coagulation factors initiate a cascade of events that 
culminate in the activation of platelets and the key protease FIIa. Thrombin forms an amplification loop by 
activating itself and other coagulations factors as well as platelets. (B) Activated platelets then aggregate to 
form platelet plugs, which serve as scaffolds for fibrin clots. (Luan D et al., 2007). 
 
Other functions of TF are the promotion of tumor-associated angiogenesis (Contrino J et 
al., 1996), blood vessel development (Carmeliet P et al., 1996) wound healing (Nakagawa 
K et al., 1998), transmission of intracellular signals (Røttingen JA et al., 1995; Sørensen 
BB et al., 1999), tumor metastasis (Mueller BM et al., 1992), promotion of cell adhesion 
and (trans)migration (Ott I et al., 1998), inflammation (Taylor FB et al., 1998; Camerer E et 
al., 2000). 
Several cellular types express TF: endothelial cells, vascular smooth muscle cells and 
monocytes/macrophages. Endothelial TF is induced by cytokines such as tumor necrosis 
factor-α (TNF-α), interleukin-1β, or CD40 ligand. (Steffel J et al., 2005; Bavendiek U et al., 
2002). These mediators share similar signal transduction pathways like MAP kinases p38, 
p44/p42 (ERK), and c-jun terminal NH2-kinase (JNK) (Mechtcheriakova D et al., 2001). 
These signal transduction molecules stimulate TF promoter by activating transcription 
factors such as AP-1, nuclear factor (NF)-κB and EGR-1 (Mackman N et al., 1997) with the 
final TF mRNA upregulation.  
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Vascular smooth muscle cells express low basal levels of TF (Xuereb JM et al., 1997). TF 
expression in these cells is induced by endotoxin, PDGF-BB, aggregated LDL and 
lysophosphatiditic acid. It’s known that in rat vascular smooth cells, ERK is involved in TF 
expression to lysophosphatiditic acid and PDGF-BB, p38 and PI3-kinase don’t play a role. 
(Schecter AD et al., 1997; Llrorente-Cortés V et al., 2004; Kamimura M et al., 2004; Cui 
MZ et al., 2003).  
Monocytes show very low basal expression of TF, but inflammatory stimuli such as C-
reactive protein, CD40 ligand. PDGF-BB, angiotensin II and oxidized LDL can induce TF in 
these cells (Cermak J et al., 1993; Mach F et al., 1997; He M et al., 2006; Wada H et al., 
1994). One of the most studied stimuli in this cell type is endotoxin, particularly 
lipopolysaccharide (LPS). It’s known that LPS stimulation of monocytes induces TF 
expression by p38, ERK and JNK pathway, leading to a nuclear translocation of EGR-1, c-
Fos/c-Jun, and c-Rel/p65. These transcriptional factors bind specific sites on TF promoter 
and mediate the endotoxin-induce increase in TF mRNA transcription (Mackman N et al, 
1997). 
Tissue factor is not only present in cells like transmembrane protein but it’s also present in 
the blood stream, referred to as circulating or blood-borne TF (Giesen PL et al., 1999). 
This form is mainly associated with microparticles originating from cell types expressing TF 
(Mallat Z et al., 2000). Monocytes are known to exchange microparticles-bound TF with 
platelets and because megakaryocytes do not express TF, it is likely that this exchange 
represents a mechanism through which platelets are loaded with TF (Scholz T et al., 
2002). 
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AIM 
 
 
In this study, we tested the hypothesis that phagocytosis of PM10 by differentiating 
macrophages in the lung is involved in the pathogenesis of the resulting pro-coagulant 
state by inducing pro-inflammatory mediators and TF, and we investigated the 
mechanisms which are responsible of these effects.  
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MATERIALS AND METHODS 
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MATERIALS AND METHODS 
 
Subjects 
Peripheral blood leukocytes were isolated from 6 healthy male control subjects with normal 
coagulation and iron metabolism parameters and without cardiovascular disease. They 
were healthy volunteers, whose age was comprised between 20 and 40 years, with serum 
ferritin (50-150 ng ml-1) and transferrin saturation (25-45%) within the normal range, and 
without a previous history of cardiovascular disease. Written informed consent was 
obtained by each subject included in the study, which was approved by the Institutional 
Review Board of the Fondazione IRCCS Ca’ Granda. 
 
Primary test article 
As a model of PM10, we used standard Fine Particulate Matter (<10µm; SRM-1648a, NIST 
Standard Reference Materials®, SRM, Gaithersburg, MD) (Akhtar, et al. 2010). Detailed 
characterization is available online via National Istitute of standards and Technology 
(2012). 
 
Isolation and treatment of human differentiating macrophages 
Mononuclear cells were separated using the lymphoprep method from 200 mL of 
peripheral blood anticoagulated with citrate 3.2% (Valenti, et al. 2011). Blood was diluted 
with Hanks’ Balanced Salts Solution, stratified on lymphoprep solution and centrifuged at 
480 g for 30 minutes. The mononuclear cells ring was collected and washed (x3) in 
phosphate-buffer saline (PBS). The cellular pellet was then resuspended in RPMI 1640 
medium supplemented with 10% fetal bovine serum, 1% β-mercaptoethanol, and 1% 
glutamine.  
After 24 hours, the supernatant was removed leaving macrophages attached. Fresh 
medium without fetal bovine serum (FBS) was then added, and cells were untreated or 
treated with: PM10 (concentration range starting from 5 up to 100 µ mL-1), 150µM Ferric 
Ammonium Citrate (FAC), 10µM Cytochalasin D  (CytD; Sigma Aldrich, St Luis, MO), 25 
ng mL-1 Macrophage Colony-Stimulating Factor (M-CSF - Sigma-Aldrich, St. Luis, MO), 
10µM UO126 ethanolate (selective inhibitor of MEK1/2 of MAP kinase pathway, upstream 
of ERK 1/2) or 60µg mL-1 melamin beads of 3-10 µm diameter conjugated with fluorescein 
isothiocyanate (FITC) (Sigma Aldrich, St Luis, MO). 
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Confirmation of PM phagocytosis 
After 6 hour exposure to PM10 or fluorescent beads, differentiating macrophages were 
detached and harvested from culture Petri dishes using PBS, Glucose 10mM, and EDTA 
3mM, and stained in the dark at 4°C for 20’ with 7-amino actinomycin-D (7AAD) to exclude 
dead cells. PM phagocytosis was estimated in at least 3x103 cells by detecting variations 
in morphology (side scatter, SSC-A), and directly measured with fluorescent beads by 
measuring FITC fluorescence by the FACSCantoII apparatus equipped with FACSDiva 
software (Becton Dickinson, East Rutherford, NJ, USA). 
 
In vivo model 
Six weeks-old male Sprague-Dawley rats (200g) were purchased from Charles River 
(Calco, Italy) and were acclimatised for one week before treatment. Rats were maintained 
at the Preclinical Research Center of the Fondazione IRCCS Ca’ Granda Ospedale 
Policlinico Milano, Italy, in compliance with the Principles of Laboratory Animal care (NIH 
publication no. 86-23, 1985). The experimental protocol was approved by the Italian 
Ministry of Health Review Board (prot. 13/10). Animals were housed at constant room 
temperature (23°C) under 12 hours light/dark cycles with ad libitum access to water.  
Rats were anesthetised with tribromoethanol (300 mg/kg, i.p.). After oral application of 
lidocaine hydrochloride 10% spray, and next intubated under vision with an otoscope with 
a 16 Gauge guide wire. Rats (6 per treatment group for each time point) received either a 
single intra-tracheal instillation of 10mg kg-1 of PM10 resuspended in 0.2 mL of saline, or 
vehicle alone, and were sacrificed after 24 hours. A sham control group that underwent the 
intubation procedure only was also evaluated. The experimental protocol was approved by 
the Italian Ministry of Health (protocol 11/13). Rat TF plasma levels were measured by 
enzyme-linked immunosorbent assay (Cusabio Biotech Co., Ltd, Wuhan, China). 
 
Total RNA isolation 
RNA was isolated from cells using the TRIzol® reagent (Life Technologies, Carlsbad, CA), 
according to manufacturer’s instructions, and dissolved in 10µl diethylpyrocarbonate 
(DEPC) treated water (Life Technologies). First-strand cDNA was synthesized from equal 
amounts (1µg) of total RNA by the Superscript VILO cDNA synthesis kit (Life Techologies) 
with random hexamers.  
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Gene expression analysis 
Quantitative real time PCR (qRT-PCR) analysis was performed using the SYBR green 
chemistry (Life Technologies). We evaluated in human macrophages and in rat tissues the 
expression of Tissue Factor (TF), Interleukin-6 (IL-6), Macrophage Chemoattractant 
Protein-1 (MCP1) and Tumor Necrosis Factor α (TNF-α). The expression of all genes was 
normalized using the housekeeping genes β-actin and HPRT in humans, and β-actin and 
GUSB in rats. The primers used are listed in Table 1. All the reactions were performed in 
triplicate by the Life Technologies ABI7500 Fast Analyzer (Life Technologies) in a 25µL 
final volume. Results were confirmed in at least three independent experiments.  
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TABLE 1. Primers sequences used in Real Time PCR for human and rat samples. 
 
HUMAN PRIMER FW (5’- 3’) PRIMER REV (5’- 3’) 
TF CCGAACAGTTAACCGGAAGA CCCACTCCTGCCTTTCTACA 
IL-6 CCTTCCAAAGATGGCTGAAA CAGGGGTGGTTATTGCATCT 
TNF-
alpha TCAGCCTCTTCTCCTTCCTG TGAGGTACAGGCCCTCTGAT 
MCP-1 CCCCAGTCACCTGCTGTTAT TGGAATCCTGAACCCACTTC 
TFPI AGATACGGAGTTGCCACCAC ACCATTCGGACCATCTTCAC 
SOD2 CAAATTGCTGCTTGTCCAAA TCTTGCTGGGATCATTAGGG 
HMOX1 CCTGCTCAACATCCAGCTCT GGGGCAGAATCTTGCACT 
β-
ACTIN GGCATCCTCACCCTGAAGTA GGGGTGTTGAAGGTCTCAAA 
HPRT GCTTGCTGGTGAAAAGGACCTCTCGAAG CCCTGAAGTACTCATTATAGTCAAGGGCAT 
RAT PRIMER FW (5’- 3’) PRIMER REV (5’- 3’) 
TF CCGAGACACAAAAATTGGACA TGAGTGTTTCTCCCAGGACAC 
β-
ACTIN ATGGTGGGTATGGGTCAGAA GGGGTGTTGAAGGTCTCAAA 
GUSB ATGCAGTTGTGTGGGTGAAT AGTAGTTCACCAGCCCAACG 
 
 
TF: Tissue Factor, IL-6: Interleukin-6, TNF-α: Tumor Necrosis Factor alpha, MCP-1: Macrophages 
Chemoattractant Protein-1, TFPI: Tissue Factor Pathway Inhibitor, HPRT: Hypoxanthine-guanine 
phosphoribosyltransferase, GUSB: β-Glucuronidase. 
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Western Blotting 
Harvested differentiating macrophages were washed three times with PBS and next lysed 
in RIPA lysis buffer in the presence of proteases and phosphatases inhibitors. Proteins 
were quantified with BCA protein assay reagent (Pierce, Rockford, IL). Equal amounts of 
proteins (25 µg) were separated by SDS-PAGE gel electrophoresis and transferred onto 
nitrocellulose membranes (BioRad, Hercules, CA). Membranes were incubated with 
monoclonal anti-TF (Novus Biological, Littleton CO, USA), polyclonal anti-β-actin (Santa 
Cruz Biotechnology Inc., Santa Cruz, CA, USA), polyclonal anti-phosphoERK1/2, 
polyclonal anti-ERK1/2 (Cell Signaling, Danvers, MA); polyclonal anti-rat TF (Bioss Inc. 
MA, USA). Horseradish peroxidase-conjugated secondary antibodies were from Santa 
Cruz Biotechnology Inc. (Santa Cruz). Enhanced chemiluminescence reagents were from 
BIORAD (BioRad). Image acquisition was performed by the Molecular imager Chemi Doc 
XRS Imaging system and protein expression quantified by proprietary software (BioRad). 
 
Immunofluorescence analysis  
Macrophages were fixed on chamber slides (Lab-Tek, Sigma Aldrich, St. Louis, MO) by 
4% formaldehyde (Carlo Erba, Milan, Italy) and permeabilized with 0.025 Triton X-
100(Sigma Aldrich, St. Louis, MO). Cells were then stained with monoclonal anti-human 
CD142 (TF) PE (Phycoerythrin)-coniugated (BD Pharmingen, NJ). Nuclei were stained 
with DAPI (Life Technologies, Carlsbad, CA). Samples were studied using Leica 
Microsystems DM IRE 2 (Leica Microsystems, Wetzlar, Germany). The post acquisition 
processing and analysis of the images was performed using the FW4000I software (Leica 
Microsystems). 
 
Prothrombin time evaluation 
To measure prothrombin time (PT), a reference platelet poor plasma (100 µl) was spiked 
with 10x concentrated (by Centricon Plus-20 Centrifugal Filter Unit, Merck Millipore, 
Darmstadt, Germany) surnatants from differentiating macrophages (100 µl) at 37°C in the 
presence of excess calcium chloride (25mM) to trigger the coagulation cascade (without 
addition of phospholipids), and the time lapse since the addition of calcium to the formation 
of the fibrin clot measured.  
 
Statistical Analysis 
Data are expressed as means ± SD and mean values were compared with one-way 
ANOVA, and post-hoc tests, when required. Log transformation was applied before 
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analysis for non-normally distributed variables. Differences were considered significant 
when p-values were <0.05. 
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RESULTS 
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Effect of PM10 on inflammatory and procoagulant genes in human differentiating 
macrophages 
The expression of a panel of pro-inflammatory and pro-coagulant genes (IL-6, TNF-α, 
MCP-1, and TF) in primary human macrophages at an early stage of differentiation (M0) 
treated or not with PM10 is shown in Fig. 1(A-E). By a dose-response study, TNF-α and 
MCP1 were significantly induced by 40 µg mL-1 PM10, whereas IL-6 was not (Fig. 1A). TF 
mRNA levels were consistently up-regulated in macrophages exposed to PM10 in a dose-
response manner, starting from 10 µg mL-1, up to 100 µg mL-1 PM10, as compared to no 
treatment (Fig.1B).  
Time course expression analysis showed that TNF-α and IL-6 mRNA levels were 
increased following PM10 treatment, whereas MCP-1 was not (Fig. 1C). TF expression in 
response to 60 µg mL-1 PM10 increased whitin 2 hours of treatment as compared to no 
treatment, and reached a plateau after 4-8 hours (Fig.1D). In contrast, we did not observe 
a significant increase in the expression of the naturally occurring anticoagulant TF 
Pathway Inhibitor (TFPI; Fig. 1E). Based on these results, in subsequent experiments cells 
were treated with PM10 for 8 hours. 
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Fig. 1. 
 
Figure 1. Expression of prothrombotic genes in primary culture of macrophages from healthy 
subjects: PM10 induces TF, but not TFPI mRNA expression in human differentiating macrophages. 
Data are presented as means ± SD of three independent experiments; mRNA levels were normalized to 
housekeeping genes expressions. *P<0.05 **P<0.005, ***P<0.0005 versus untreated (fold increase). The 
dotted line (set at zero logs) indicates the baseline level in control cells. (A) Expression of IL-6, TNF-α, MCP-
1, after 24 h exposure to PM10 (concentration range 10–100 µgml–1). (B) Dose–response effect of PM10 on 
TF mRNA levels, as compared to untreated cells. (C) Time course analysis of TNF-α, IL-6 and MCP-1 
expressions following exposure to 60 µgml–1 PM10. (D). Time course analysis of TFmRNA expression 
following exposure to 60 µgml– PM10. (E) Time course analysis of TFPI expression following exposure to 60 
µgml-1 PM10. IL, interleukin; MCP, macrophage chemoattractant protein; TF, tissue factor; TFPI, tissue factor 
pathway inhibitor; TNF, tumor necrosis factor.  
 
 
Upregulation of TF mRNA levels in response to PM10 starting after 2h of exposure to PM10 
translated into an increased protein expression after 8h, as compared to vehicle alone 
(Fig. 2A). Immunofluorescence analysis confirmed that TF protein is induced in PM10-
treated macrophages, and suggest that it is localized on the cell surface, although we 
cannot exclude concurrent diffuse cytoplasmic localisation (Fig. 2B).  
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The impact of the secretomes obtained from macrophages treated or not with PM10 on the 
activation of the coagulation cascade was next studied by testing their influence on the 
prothrombin time (PT) of one control plasma. There was a significant reduction in the 
clotting time of control plasma mixed with supernatant of differentiating macrophages 
treated PM10 vs. those treated with vehicle alone (Fig. 2C). 
These results suggest that PM10 exposure induces a procoagulant phenotype in human 
differentiating macrophages. 
Fig. 2. 
 
 
Figure 2. PM10 induces TF protein in human differentiating macrophages. (A) Induction of TF protein 
expression after 8 h PM10 exposure (60 µgml–1); β-actin is shown as loading control. Quantification of relative 
TF tissue factor protein levels (47 kDa) by Western blotting was normalized for β-actin (43 kDa); one of two 
independent experiments is shown. *P<0.05. (B) Immunofluorescence after 24 h exposure to 60 µgml–1 
PM10. Nuclei were stained with DAPI (blue) and TF was stained with PE conjugated antibody (red). (C) 
Prothrombin time was evaluated by adding supernatants from differentiating macrophages treated or not with 
60 µgml–1 PM10. ***P<0.0005. PE, phycoerythrin; PM10, particulate matter<10 µm in diameter; TF, tissue 
factor. 
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Phagocytosis of PM10 is required but not sufficient for TF induction 
To evaluate whether the upregulation of TF expression induced by PM10 is influenced by 
cellular differentiation in vitro, macrophages were treated with macrophage colony-
stimulating factor (M-CSF) to induce M2 polarization (as confirmed by gene expression 
analysis; data not shown). Differently from M0 macrophages, M2 macrophages did not 
upregulate TF in response to PM10 (Fig. 3A). 
As differentiated macrophages display reduced phagocytic activity (Daigneault, et al. 
2010), we next tested the hypothesis that TF induction was mediated by phagocytosis of 
PM10. To this end, cells were untreated or treated with CytD, an inhibitor of actin 
polymerization and of phagocytosis (Wakatsuki, et al. 2001). CytD completely abolished 
TF induction by PM10 (Fig. 3B). To evaluate whether phagocytosis per se is sufficient to 
induce TF expression, we next challenged differentiating macrophages with 3µm and 10 
µm beads (Fig. 3B). Treatment with both 3µm, but not 10 µm beads, caused a small 
increase in TF mRNA levels, which was markedly lower to that of PM10, and was 
suppressed by pretreatment with CytD. 
Confirming PM phagocytosis, treatment with both PM10 and 3 µm inert beads increased 
membrane complexity (Side Scatter Area-SSC-A), whereas inhibition of phagocytosis by 
CytD completely blunted the effect (Fig. 3C). Furthermore, a strong uptake of 3µm 
fluorescent beads could be directly confirmed, which was also inhibited by pretreatment 
with CytD (Fig. 3D). A small increment of phagocytosis was also confirmed for 10µm inert 
beads, although it was restricted to a smaller percentage of cells (Fig. 3D and not shown). 
These data suggest that phagocytosis of inert materials smaller than 10 µm by 
macrophages is sufficient to elicit TF expression, but cannot fully recapitulate the effect of 
PM10 exposure. 
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Fig. 3. 
 
Figure 3. TF induction is dependent upon PM10 phagocytosis in differentiating human macrophages. 
(A) Effect of M2 polarization on PM10-dependent induction of TF expression in human differentiating 
macrophages treated with MCSF (inducing a M2 phenotype) or untreated (M0 phenotype). (B) Effect of 
phagocytosis inhibition by pretreatment with 10 µM CytD, and of aspecific stimulation of phagocytosis by 60 
µgml–1 polystyrene beads of 3–10 µm diameter on TF mRNA expression at 8 h in differentiating 
macrophages. *P<0.05 **P<0.005, ***P<0.0005 versus untreated. #P<0.05 versus absence of CytD 
pretreatment. (C) Effect of manipulation of phagocytosis by inhibition with 10 µM CytD on side scatter 
parameter (SSC-A) of differentiating macrophages treated with 60 µgml–1 inert beads of 3 µm and 10µm of 
diameter and with 60 µgml–1 PM10. *P<0.05, ***P<0.0005 versus untreated. #P<0.05 versus absence of CytD 
pretreatment. (D) Relative fluorescence of macrophages exposed to inert beads labeled with FITC. 
***P<0.0005, *P<0.05 versus untreated. #P<0.05 versus lack of CytD pretreatment. CytD, cytochalasin D; 
FITC, fluorescein isothiocyanate; PM10, particulate matter<10 µm in diameter; SSC-A, side scatter area; TF, 
tissue factor. 
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Particulate Matter (<10µm in diameter) exposure, iron metabolism, and ERK 
pathway activation in the regulation of TF in macrophages  
 
We next tested whether oxidative stress triggered by metals included in the particulate was 
involved in the induction of TF in macrophages exposed to PM10. In particolar we evacuate 
the role of iron, by analyzing the mRNA expression of iron metabolism genes in 
macrophages exposed to or not to PM10 (Fig. 4A). A transient induction of iron hormone 
hepcidin (HAMP) was observed after 8 hours of PM10 treatment, with subsequent 
downregulation at 24 hours. In contrast, the iron exporter and hepcidin receptor 
Ferroportin-1 (FPN1) was downregulated at 8 hours. Heavy chain ferritin (FTH1) and 
transferrin receptor-1 (TfR1) expression were not significantly modulated. These data are 
consistent with a transient retention of pro-oxidant iron upon PM10 exposure, mediated by 
upregulation of hepcidin and suppression of FPN1. Remarkably, exposure to iron salts 
(FAC 150µM for 24 hours) was also associated with upregulation of TF mRNA levels (Fig 
4B).  
To confirm that PM10 exposure leads to oxidative stress in differentiating macrophages, we 
measured mRNA expression of MnSOD2 and HMOX1, two pivotal genes for cellular 
antioxidant defences. We found that at 8h both SOD2 and HMOX1 are significantly in cells 
exposed vs. those not exposed to PM10 (Fig. 4C).  
Treatment with equimolar desferrioxamine, an extracellular iron chelator, was able to 
inhibit the-iron mediated induction of TF expression. However it did not suppres he effect 
of PM10 on TF induction (data not shown). However, PM10 particles contain large quantities 
of iron and other toxic divalent metals, that when released within intracellular vacuoles 
after phagocytosis, are not accessible to desferrioxamine. On the other hand, 
desferrioxamine increases the expression of transferrin receptor and iron carriers 
mediating cellular iron uptake. Therefore, based on these data, it cannot be excluded that 
iron is involved in TF induction by PM10. 
As activation of the ERK pathway is involved in regulation of TF expression (Biswas, et al. 
2012) and is induced by iron overload (Dongiovanni, et al. 2010), we looked at whether 
ERK was also influenced by FAC in human differentiating macrophages. As shown by 
Western blotting in Fig. 4D, activation of ERK1/2 pathway (increased phosphorylation 
status) was observed in macrophages following FAC exposure.  
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Fig. 4. 
 
Figure 4. FAC induces TF expression in macrophages. (A) Time course expression of HAMP, FPN1, 
FTH1 and TFRC in differentiating human macrophages treated or not with 60 µgml–1 PM10. (B) TF mRNA 
expression in differentiating macrophages treated with 150 µM FAC for 24 h. (C) SOD2 and HMOX1 mRNA 
levels in differentiating macrophages treated or not for 8 h with 60 µgml–1 PM10. (D) Activation of ERK1/2 
pathway in macrophages exposed to 150 µM FAC for 8 h. Results are from three independent experiments, 
and were normalized for housekeeping gene expression. *P<0.05. FAC, ferric ammonium citrate; FPN1, 
ferroportin-1; FTH1, H ferritin; HAMP, hepcidin; HMOX1, heme oxygenase 1; PM10, particulate matter<10 µm 
in diameter; SOD2, superoxide dismutase 2; TF, tissue factor; TFRC, transferrin receptor-1. 
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In line with a possible role of iron in determining a procoagulant phenotype in 
macrophages, we found that ERK1/2 is phosphorylated and activated in macrophages 
after PM10 exposure, reaching a plateau at 8 hours preceding and next paralleling TF 
expression (Fig. 5A). To evaluate whether ERK activation is required for PM10 induction, 
macrophages were pre-incubated with the ERK inhibitor UO126. UO126 pretreatment 
abrogated PM10-induced ERK activation, but only partially moderated TF upregulation 
caused by PM10 exposure (Fig. 5B). These data suggest that ERK1/2 pathway activation is 
implicated, but is not sufficient for full TF upregulation caused by PM10 exposure.  
 
Fig. 5. 
 
Figure 5. Activation of the ERK pathway is involved but not necessary for PM10-mediated induction of 
TF in human differentiating macrophages. (A) Time course analysis of ERK activation status following 
exposure to 60 µgml–1 PM10or not in human differentiating macrophages evaluated by Western blotting. 
Relative quantification of ERK activation status (pERK/ERK) is represented in the bar chart in the upper part 
of the figure. β-actin is shown as a further loading control. (B) Effect of inhibition of the ERK pathway by pre-
treatment with 10 µM UO126 on 60 µgml–1 PM10 mediated induction of TF mRNA in differentiating 
macrophages. The correspondent effect on the activation status of the ERK pathway, evaluated by Western 
blotting is shown in the bottom part of the figure. Results are from three independent experiments, and were 
normalized for housekeeping gene expression. *P<0.05 versus untreated. #P<0.05 versus lack of UO126 
pretreatment. PM10, particulate matter<10 µm in diameter; TF, tissue factor.  
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Effect of tracheal instillation of PM10 (<10µm in diameter) on lung Tissue Factor 
expression  
To assess the systemic effects of PM10 exposure on TF in vivo, PM10, or vehicle alone, 
were instilled intra-tracheally in rats. PM10 exposure was associated with macrophage 
activation and induction of cytokines. Indeed, upregulation of mRNA expression of IL-6, 
typical of M1 macrophages and of IL10, typical of M2 macrophages, were detected 
following exposure to PM10 (Fig. 6A). Accordingly, while saline treated animals 
demonstrated regular alveolar spaces containing scattered macrophages after 
hematoxylin and eosin (H&E) staining separated by normal septa (Fig. 6B), in PM10 treated 
animals septa appeared diffusely thicker and more cellular, with marked reduction of the 
alveolar spaces. Nevertheless, intra-alveolar cellularity was not increased.  
Upregulation of TF mRNA levels at 24 hours was specifically detected in the lungs of rats 
instilled with PM10 vs. those treated with saline alone (Fig. 6C), and sham-treated animals 
(not shown), whereas no significant differences were observed in TF expression in the 
liver and spleen. Increased TF mRNA levels translated in upregulation of TF protein 
expression in rats exposed to PM10 vs. controls (Fig. 6D), which resulted in a significant 
increase in plasma TF levels in rats treated with PM10 compared to those instilled with 
saline (shown in Fig. 6E as log circulating levels). Indeed, plasma TF was about 0.3 logs 
higher in rats exposed to TF than in controls, corresponding to an almost twofold increase 
in absolute levels.  
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Fig. 6. 
 
 
Figure 6. Effect of PM10 endotracheal instillation on TF expression in rats. (A) Gene expression profile 
of macrophages of rat lung tissue. Them RNA expression of IL-6 and TNF-α (M1 cytokines) and of IL-10 and 
IL-4 (M2 cytokines) was normalized for housekeeping gene expression. (B) Rat lung sections comparing 
controls (left column) to PM10-treated animals (right column) stained with hematoxylin and eosin (×40). 
Regular alveolar spaces containing scattered macrophages separated by normal inter-alveolar septa are 
evident in controls. In PM10-treated animals, septa appear diffusely thicker and cellular, with marked 
reduction of the alveolar spaces; nevertheless, intra-alveolar cellularity is not significantly increased. (C) TF 
mRNA levels in rat lung, liver and spleen tissues after 24 h since instillation of saline or PM10. Results are the 
mean of six independent samples obtained from each rat, and were normalized for housekeeping gene 
expression. (D) TF protein expression in lung tissue after 24 h since instillation of saline or PM10. β-actin is 
shown as loading control. Relative quantification of TF expression compared to β-actin is provided in the bar 
chart. (E) TF plasma levels (logs) in rats after 24 h since instillation of saline or PM10. *P<0.05 vs. saline-
treated rats. IL, interleukin; PM10, particulate matter<10 µm in diameter; TF, tissue factor; TNF, tumor 
necrosis factor. 
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DISCUSSION 
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DISCUSSION 
In this paper, we evaluated the role of phagocytosis of PM10 by differentiating 
macrophages in the pathogenesis of the pro-coagulant phenotype associated with PM10 
exposure, by a complementary approach exploiting in vitro human differentiating 
macrophages and in vivo challenge of rat lung. The main findings were that TF induction in 
response to PM in human differentiating macrophages is dependent on phagocytosis and 
on activation of the ERK1/2 stress signalling pathway, and it is influenced by PM diameter 
and composition. Furthermore, intratracheal instillation of PM10 results in the recruitment of 
phagocytes in rat lung with specifically local increased expression and release of TF. 
First, we observed a strong and consistent upregulation of transcription and consequently 
cell surface expression of TF, the trigger of the extrinsic pathway of the coagulation 
cascade. TF mRNA upregulation, as compared to no treatment, happened within a few 
hours and peaked at 8 hours after PM10 exposure, while we observed the maximum TF 
protein induction at 8h. These findings confirm and extend previous data, based on 
qualitative analyses, suggesting that TF mRNA levels are increased in macrophages 
treated with PM10 (Gilmour, et al. 2005). We carefully quantified mRNA expression of TF, 
characterizing the kinetic and dose-response effect.  
Differently from other proinflammatory stimuli in macrophages, PM10 did not concomitantly 
induce the expression of TFPI, the physiological inhibitor of TF acting as a cofactor for 
protein S on FXa and resulting in a negative feedback on TF/FVIIa complex (McGee, et al. 
1994). Furthermore, we confirmed TF protein upregulation, demonstrating increased 
surface expression of TF in cells exposed to PM10, which represents a novel finding, and 
confirmed a functional effect on the activation of coagulation by showing an impact on 
Prothrombin Time. These data suggest that exposure to PM induces a procoagulant 
imbalance in human differentiating macrophages.  
PM10 exposure also increased macrophage mRNA expression of TNFα and IL-6 (Michael, 
et al. 2013). These cytokines are involved in airway inflammation, and may be implicated 
in the secondary release of procoagulant mediators, such as Plasminogen Activator 
Inhibitor-1 (PAI-1) (Budinger, et al. 2011). However, the induction was less marked than 
that of TF, and was not consistent in all subjects evaluated. Interestingly, macrophages 
differentiated towards the M2 anti-inflammatory profile, which are known to display 
reduced phagocytic activity (Daigneault, et al. 2010), were not competent for induction of 
TF by PM10. This novel finding may contribute explaining previous discordant results 
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concerning the effect of PM10 on TF in different cell subsets of monocyte-derived lineage 
(Gilmour, et al. 2005, Michael, et al. 2013). 
To evaluate whether phagocytosis of PM10 is required for TF induction, we pre-treated 
macrophages with the phagocytosis inhibitor CytD, and evaluated TF expression following 
phagocytosis of PM10 or inert beads with similar diameters. CytD completely abolished 
PM10-related induction of TF. Furthermore, 3 µm inert beads induced a small increase of 
TF expression, which was again dependent on phagocytosis, whereas larger 10 µm beads 
were not consistently phagocytosed and did not induce TF. These results are consistent 
with epidemiological evidence indicating that fine particulate matter (PM2.5) has more 
detrimental effect on human health than coarser particulate (Gualtieri, et al. 2010). 
However, the effect of PM10 on TF expression was larger than that of 3 µm inert beads, 
though the latest were phagocytosed with at least the same efficiency. Therefore, the 
composition of the particulate seems to have a pivotal role in triggering a procoagulant 
phenotype in macrophages. 
PM is indeed a mixture of compounds also including iron and transition metals, which may 
be involved in TF induction after phagocytosis by induction of oxidative stress. Under 
inflammatory conditions, there is an increase of iron uptake and a repression of iron export 
mechanisms, which leads to iron sequestration in macrophages (Valenti, et al. 2011), 
favored by the induction of iron storage protein ferritin (Torti and Torti 2002). We found that 
hepcidin, the hormone inhibiting iron export from cells, was transiently induced following 
PM10 exposure, whereas at the same time FPN1, the cellular iron exporter inhibited by 
hepcidin, was downregulated. These data suggest that PM10 exposure is associated with 
modulation of iron genes favouring the retention of iron and other divalent pro-oxidant 
transition metals within macrophages. Since the ERK stress kinase pathway induces TF in 
macrophages upon inflammatory pro-oxidant stimuli (Khan, et al. 2010, Steffel, et al. 
2006), we next tested the role of ERK1/2 in TF induction by PM10. Indeed ERK1/2 was 
rapidly activated by phosphorylation following PM10 exposure, but TF induction was only 
partially blunted by pharmacological inhibition of ERK1/2. Therefore, other still not 
characterized signalling pathways must be involved in TF induction by PM10. 
Finally, in order to assess the translational relevance of these findings, we compared the 
effect on instillation of PM10 or vehicle alone in the lower airways on TF expression in rats. 
In keeping with in vitro results, PM10 exposure induced pulmonary inflammation and 
macrophage activation, as assessed by histological evaluation and expression of 
cytokines. Lung inflammation was associated with recruitment of inflammatory cells, and 
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increased TF mRNA and protein levels. Pertaining to the global coagulation state, rats 
instilled with PM10 showed an almost twofold higher plasma TF than controls, suggesting 
that increased release of TF from the lungs in response to airway exposure to PM10 may 
shift the systemic coagulation balance towards a prothrombotic state. These data are in 
agreement with the recently reported upregulation of serum TF activity following PM10 
inhalation in rats (Frederix, et al. 2008). Interestingly, we observed that TF induction was 
specific for the lung, suggesting that the effect is directly related to PM10 phagocytosis and 
inflammation in the lower airways, and not secondary to the release of inflammatory 
mediators, such as IL-6, by the liver or the spleen, due to systemic translocation of metals 
contained in inhaled particles (Wallenborn, et al. 2007). It should be noted that these 
results does not exclude that other mechanisms, such as induction of the anti-fibrinolytic 
molecule PAI-1 (Budinger, et al. 2011), or TF induction by PM10 in endothelial cells 
(Karoly, et al. 2007, Snow, et al. 2014), is involved in tipping the balance of the coagulation 
pathway towards thrombus formation after exposure to fine PM.  
In summary, we showed that in human differentiating macrophages, PM10 exposure 
consistently induced TF membrane expression and a procoagulant phenotype. TF 
induction required phagocytosis of PM, was associated with a gene expression profile 
favouring the intracellular retention of iron, a pro-oxidant transition metal, and was partially 
mediated by the stress kinases ERK1/2. In rats, alveolar exposure to PM10 was associated 
with pulmonary inflammation with local, but not systemic, induction of TF, resulting in 
increased circulating TF levels. In conclusion, TF induction by lung macrophages activated 
following phagocytosis is likely involved in the pathogenesis the increased risk of 
thromboembolic complications associated with PM exposure. 
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